 Research
 Open Access
 Published:
Multilevel model on longitudinal data analysis in determinants of CD4 cell count among antiretroviral therapy attendant of HIV infected adults follow up in Gondar Teaching Referral Hospital, Gonder, Ethiopia
AIDS Research and Therapy volume 18, Article number: 5 (2021)
Abstract
Background
Human immunodeficiency virus attacked an immune cell and the CD4 cell which is responsible for the body’s immune to infectious agents. Acquired immunodeficiency syndrome is one of the major public health problems in SubSaharan Africa including Ethiopia. The main objective of this study to identify the determinants of CD4 cell count among antiretroviral therapy attendants of infected adults follow up in Gonder teaching referral hospital, Gonder, Ethiopia implemented by SAS version 94.
Methods
A retrospective cohort study was conducted on 216 regular follow up patients whose age greater than 14 years from December 1, 2012, to December 30, 2017. A multilevel model was used to identify the factors of CD4 cell count of patients and it considered variability between and within patients.
Results
The mean with a standard deviation of weight, and a hemoglobin level of patients were 55.48 (10.21), and 18.25 (33.028) respectively. This study concluded that the variation for CD4 cell count existed between patients was 63% and the remaining 37% of variation existing within patients. In this study, the random coefficient timevarying covariate model was well fitted which shows weight and hemoglobin level were statistically significant predictors at a 5% level of significance for the log of CD4 cell count of patients.
Conclusion
This study shows the hemoglobin level and weight of patients were statistically significant for the log of CD4 cell count of patients follow up in Gonder teaching referral hospital, Gonder, Ethiopia. Moreover, the result of the study shows that the log of CD4 count of patients increased when hemoglobin level and weight of patients increased. Hence, intervention should be given the ways to increase weight and hemoglobin levels of patients during follow up of antiretroviral therapy.
Introduction
Acquired Immune Deficiency Syndrome (AIDS) is caused by HIV (Human Immune Deficiency Virus) which reduces a person’s ability to fight infection. HIV attacks an immune cell and the CD4 cell is responsible for the body’s immune response to infectious agents. An uninfected individual has around 1100 CD4 cells per milliliter of blood. These CD4 cells, decrease in number with time from HIV, so that an infected person’s CD4 cell count can be used to monitor the progression of the disease [1].
Women account for nearly half of the 40 million people living with HIV1 worldwide which has a higher proportion existing in developing countries and the human immunodeficiency virus–type 1 (HIV1) is epidemic for more than 20 years [2]. ART can be helpful for people who have AIDS when diagnosed and can be lifesaving. Treatment is important for people with HIV when people who start ART soon after they get HIV to experience more benefits from treatment than people who start treatment after they have developed AIDS [3].
SubSaharan Africa remains most severely affected, with nearly 1 in every 20 adults (4.9%) living with HIV and accounting for 69% of the people living with HIV in this worldwide. Although the regional prevalence of HIV infection is nearly 25 times higher in subSaharan Africa than in Asia, almost 5 million people are living with HIV in South, SouthEast and East Asia combined. After subSaharan Africa, the region most heavily affected the Caribbean and Eastern Europe and Central Asia, where 1.0% of adults were living with HIV in 2011 (UNAID 2012).
Immunological failure as CD4 count falls to the baseline or persistent CD4 levels of below 100 cells/mm^{3}. Virologic failure as plasma viral load above 1000 copies/ml based on two consecutive viral load measurements after 3 months, with adherence support [4]. Globally, the annual number of people newly infected with HIV continues to decline, although this varies strongly between regions. In general HIV/AIDS is one of the major public health problems in SubSaharan Africa including Ethiopia, as one of these countries has been affected by the epidemic with a prevalence was 1.5% and 1.1% in 2011 and 2015 respectively that shows urban are more affected than rural areas while females are twice affected than male population with HIV [5]. The World Health Organization (WHO) defines clinical failure amongst adults and adolescents as new or recurrent clinical conditions indicating severe immunodeficiency (WHO clinical stage 4 conditions) after 6 months of effective treatment.
Study design and methods
A retrospective cohort study design was used to collect relevant information’s from ART chart in order to address the objective of this study. Those HIV positive patients who are greater than 14 years old and start ART since December 1, 2012 and who has base line and at least three follow up period until December 30, 2017 included in this study.
Study area and population
This study conducted at Gondar Teaching Referral Hospital in NorthWestern Ethiopia, Amhara Region. The population of this study included HIV positive adults who attend antiretroviral therapy at Gondar Teaching Referral Hospital.
Data collection procedures
This study obtained data from a retrospective cohort study based on ART electronic data base and from the review of patient charts which contains sociodemography, laboratory and clinical information of all HIV patients under ART followup including a detailed antiretroviral therapy history from Gondar Teaching Referral Hospital among Antiretroviral Therapy (ART) follow up study. The target population was adults of HIV positive patients whose age greater than 14 years old who initiated on ART from December 1, 2012 to December 30, 2017 GC.
Quality of data
The data quality was controlled by data collectors from ART section of the hospital. The controllers were taken intensive training by the Minister of Health for the different services.
Variables include in the study
The longitudinal response variables for this study were CD4 cell count. Therefore, CD4 count has count variable nature due to this reason generalized linear mixed model with the link function log is performed. In addition the predictor variables were used in this study shows on Table 1.
Inclusion and exclusion criteria
Inclusion criteria: Patients whose age was above 14 years old that are attending a minimum of three visit of HAART treatment in ART clinic for refilling their prescription and who were initiated on ART from December 1, 2012 to December 30, 2017 GC at Gondar Teaching Referral Hospital would be included in the study.
Exclusion criteria: Patients whose age was below 14 years old that are attending HAART treatment in ART clinic for refilling their prescription, patients who are not registered in the ART clinic and who are not initiated on ART were not included in this study. In addition patients out of the study period are not included.
Data collection methods and procedures
This study was used secondary data extracted from patient chart followup format and analyzed by SAS version 9.4 statistical software. But the chart prepared by national health organization.
Missing data treatment
One of the biggest problems in longitudinal studies is missing data. However, multilevel analysis is no need to have complete dataset. Therefore, multilevel analysis is very flexible in handling missing data [6].
Statistical analysis technique for longitudinal data
To assess the changes of outcome (s) over time to associated risk factors by using multilevel longitudinal data. But analyzing multilevel longitudinal data is complicated. For analyzing of this longitudinal data, both descriptive and inferential statistics were used. Multilevel analysis is (probably) the most robust and flexible of the three techniques [6]. Thus, in this study multilevel longitudinal methods were employed.
Growth curve analysis
Growth curve analysis is offers a statistical framework for analyzing longitudinal data. Growth curve analyses are used to describe the patterns of change over time and to determine the number of visit time. More specifically, growth curve analysis in longitudinal data can estimate a bestfit line or curve to each individual’s responses over time [7].
There are few strict requirements for the types of data that might be analyzed using growth model. First, adequate at least 100 sample sizes are needed to reliably estimate then growth models are often preferred. Second, growth models typically require at least three repeated measures per individual. Third, for the typical method of estimation called maximum likelihood, it is assumed that the repeated measures are continuous and normally distributed.
Univariate growth curve analysis
According [8], separate growth curves are constrained to have the same slope but allowed to have different intercepts over time. As a consequence, this method underestimates variability and overestimates test statistics when individuals have different slopes.
Multilevel analysis
Longitudinal data are one example of a hierarchical structure; series of repeated measures over time at the lowest level is nested with the individual persons at the highest level. Such nested structures are typically strong hierarchies because there is much more variation between individuals in general than occasions within individuals [9].These repeated measures are taken at either fixed or varying occasion. The measurements taken as a fixed occasion, all individual provided measurements at the same set of occasions, usually regularly spaced, such as in our study every 3 months. When occasions are varying, we have different set of measures take at different points in time for different individuals [10].
Univariate multilevel analysis
This analysis is used for exploring an individual’s variability on longitudinal data for responses in such random effects or multilevel modeling allows investigate two level of variability. Therefore, within and between subjects variability were analyzed for CD4count at each individual i = 1, 2… n [11]. These models were analyzed based on either of following mechanisms.
Intercept only model
This is the simplest case of hierarchical model in which there are no explanatory variables at all. Then model has only an intercept term and variances at the measurement and individual level. Since the model does not contain a slope, the true individual change is a horizontal line with yintercept β0i.
The model expressed as:
Where, the Greek letters π and β indicate first and second level parameter respectively.
By substituting, we get
π_{0}i is the intercept for individual i for each response; β_{00}is the mean intercept over all individuals, and u_{0}i are the deviation of individualspecific residual; finally, e_{0}i is the timespecific residual. Now, proportion variance or the intra class correlation (ICC) refers to a set of coefficients representing the relationship between variables of the same individuals decomposes into two independent components (i.e., level1 and leve2). Thus, ICC explained by the individuals (level2) in the population is given by
Where, e_{0} and u_{0} for each response are different and ICCmeasures = 1 − ICCindividual.
Random intercept model
A random intercepts model is a model in which intercepts are allowed to vary, and therefore, the scores on the dependent variable for each repeated measurement are predicted by the intercept that varies across patients. The prior models are sometimes called unconditional (intercept only) model; because there are no measured covariates used to predict the random effect.
Now, based on [10], the model often interested in assessing how a longitudinal outcome is associated with a covariate whose value changes over time such covariant are called timevarying covariates X_{pi}, and whose value not changes over time called time invariant predictor Z_{si}.
Time invariant covariates Z inter the equation at the second level.
By substituting, we get a univariate random intercept model:
Where, β_{00} is the overall average intercept for each response, β_{10} is the slop of time varying covariates, β_{01} is the slop of time invariant covariates, β_{11} is the mean difference change between time varying covariates and time invariant covariates, and lastly e_{0}i and u_{0}i are still the within and between individual error term of the intercept. Therefore, in this model β_{00} + β_{10}X_{pi} + β_{01}Z_{si} + β_{11}Z_{si}X_{pi} are the fixed part, because the coefficients are fixed.
The remaining u_{0}i + e_{0}i are called the random part of the model. Where, X_{pi}, p = 1, 2,…, P denotes the P time varying covariates that were included in the analysis, and Z_{si}, s = 1, 2… S denotes the s invariant covariates that were included in the analysis.
Random coefficients model
This random coefficients model is a model in which slopes are allowed to vary in addition to intercepts for each univariate response. The relationship between an explanatory variable and the response is different across all patients with their intercept and slope by considering time varying covariate and time invariant covariate.
Time invariant covariates Z inter the equation at the second level.
By substituting, we get univariate random coefficient model:
Where, the only additional term in this model is u_{1}i the random slope of time varying covariates for response.
Selection of covariance structure
The most common covariance structures in repeated measure are: First, Simple structure species that the observations are independent, even on the same patient, and have homogeneous variance. Second, Compound symmetric structures were the observations on the same patient has homogeneous covariance and homogeneous covariance. Third, unstructured structure species no patterns in the covariance matrix, and is more appropriate for balanced data nature. Fourth, Autoregressive (order 1) covariance structure species homogeneous variance; and more appropriate for unbalanced data and equally spaced measurement times such that t_{n} + 1 − t_{n} is a constant for all n [12]. In addition to this, AR (1) model used only two parameters that are considerable superior than totally unstructured model even though − 2RLL is larger or worse [13].
Variable selection for multilevel analysis
In order to select variables to be included in multivariable analysis, forward variable selection was used. The first step in this selection is to fit a univariate multilevel model for each covariate at the 25% level. Next univariate model is fitted that contains all covariates that are significant in univariable analysis.
Model selection and comparison
In order to select the best and final model which is appropriately fits with the given longitudinal data, it is necessary to compare the different models by using different techniques and methods. Hence, Akaki information criteria (AIC) and Bayesian information criteria (BIC) that calculated from deviance based on number of estimated parameter p is also most convenient at 5% level of significance, but for multilevel model deviance information criteria (DIC) is appropriate. After all, Deviance compares Chi squared distribution with degrees of freedom equal to the difference (p) in the number of parameters fitted under the two models smaller values is better [10].
Parameter estimation
Parameter estimates of multilevel model were derived for both fixed components and random components. To estimate this component, there is different of parameter estimation technique. Among that, maximum likelihood estimation is most commonly used estimation method in multilevel model [14].
Goodness of fit test
Once a model has been developed through different techniques in estimating the model parameters, there were several mechanisms involved in assessing the appropriateness, adequacy and usefulness of the model. First t test statistic is commonly used to test significance of individual parameter regression coefficients for each independent variable. Second, the deviance based test, or likelihood ratio test is a general principle for testing fixed multiparameter and for testing about the random part of the model in applications of a hierarchical linear model.
Model diagnosis
For multilevel analysis making inference about the model depends on whether the data met the required assumptions or not. In this hierarchical regression models some graph and other techniques were used to assess peculiarities or the distinctive features of the model with regards to the data. Therefore the assumptions in this hierarchical regression models were linearity, normality, heteroscedasticity and residuals nature using usual manner.
Results
There were a total of 1408 visits from 216 subjects; the numbers of visits per subject were minimum 3 and a maximum of 10 visits with an equally 6month interval for all patients. The sample sizes at the six consecutive time points were 216, 216, 196, 167, 142, 125, 105, 93, 80 and 68. Therefore, the measurements were sharply increasing the degree of missing over time due to dropouts, missed clinic visits and transfers.
From sociodemographic and clinical related covariates results were shown in Table 2 below. Among a total of 216 respondents 131 (60.6%) were female and 98 (44.9%), 68 (31.5%), 35 (16.2%) and 16 (7.4%) of respondents were married, divorced, single and widowed marital status respectively. Besides, the functional status of patients 194 (89.8%), 20 (9.3%) and 1 (0.5%) were working, ambulatory and bedridden. Moreover, the adherence status of patients 202 (93.5%), 9 (4.2%) and 4 (1.9%) were good, fair and poor respectively. Likewise, the clinical stages of patients 179 (82.9%), 17 (7.9%), 16 (7.4%) and 2 (0.9%) were stage I, stage II, stage III and stage IV respectively. Regarding the functional status of patients 194 (89.8%), 20 (9.3%) and 1 (0.5) were working, ambulatory and bedridden respectively and TB status 192 (88.9%) were negative.
As can be seen from Table 2, the mean of baseline CD4 for patients was 301.40 (SD = 171.7). Likewise; the overall mean of CD4 count for respondents was 353.72 (SD = 189.28). Furthermore, the mean with a standard deviation of weight, hemoglobin level, and age of patients was 55.48 (10.21), 18.25 (33.028) and 35.09 (10.27) respectively.
Table 3 shows the increment of mean value of CD4 count of patients who visit for ten consecutive. However, the standard deviation was slight decreased among the ten consecutive visited.
Individual profile plot of growth curve analysis
The visualized the pattern of CD4 count measurements of the patient’s overtime and the overall individual plots were considered. Figure 1 indicated that the variability within and between patients was slightly decreasing trend on each respondent throughout the followup. For responses, most (but not all) observations were slightly turned down throughout the followup. Likewise, the variation withinsubject throughout the time decreased each response from a visit to a visit. From Table 4 results show intraclass correlation gives strong evidence that variability was occurring between the patients. Therefore, the intraclass correlation of this study was 9923.8/9923.8 + 5843.87 = 0.6294. Therefore, 63% of the variation for CD4 count existed between patients and the remaining 37% of variation existing within patients.
Table 5 shows the random coefficient timevarying covariate model was well fitted because generalized Chi square/df was closed to one. Under this study Shapiro–Wilk test of normality was used and it was show normality with a Pvalue equal to 0.0001.
Besides residuals plot shown in Fig. 2, indicate that the residuals and the fitted values confirm linearity without distinct patterns and show constant variance and the QQ plot confirms normality of errors which was residual points follow the straight dashed line. Therefore, the overall assumptions satisfied and fit the random coefficient timevarying covariate model with the selected covariates show in Table 5.
From the fitted univariate multilevel model was modeled with sets of covariates that include fixed effect parameters age, marital status, weight, hemoglobin level, functional status, WHO stage, TB screen, opportunistic infection, and ART adherence. Among those covariates, there was significance difference by intercept, weight and hemoglobin level for a CD4 count of patients. According to results intercepts, weight and hemoglobin levels were positively associated with a CD4 count of patients. Therefore, this study shows that CD4 cell count of patients increased as weight and hemoglobin levels increase (Table 6).
Discussion
Highly active antiretroviral therapy has greatly reduced morbidity and mortality in patients with human immunodeficiency virus. The effective antiretroviral therapy was important intervention in terms of improving longevity and preventing opportunistic infections in patients with human immunodeficiency virus infection. The literature and this study shows antiretroviral therapy is effective treatment for human immunodeficiency virus to reduce the viral load to undetectable levels. The studied patients received the same type of antiretroviral due to the therapeutic effectiveness and adherence. Antiretroviral drug were associated with weight gain and hemoglobin level. Human immunodeficiency virus has damaged immune system and reduced CD4 count. Highly active antiretroviral therapy will strength immune system, extend life and increased CD4 count. Weight and hemoglobin level increased due to patients received antiretroviral therapy.
Based on different wellorganized literature, some discussions were organized as follows:
In this study, the random coefficient timevarying covariate model was well fitted because generalized Chi square/df was 8.49 which closed to one. From the multilevel analysis, more than half percent of the variation was explained from between patients; and the remaining is explained by within patients. The finding is consistent with [9] that for any repeated data between variations are higher than within variation. According to this study, weight was an important predictor for a CD4 count of patients that as weight increase in 1 kg then the mean log of CD4 will be increased by 0.009483 cells per milliliter of blood (Table 6). This estimated result also consistent with similar previous studies conducted by different scholars [15, 16]. Lastly, this finding provides that the log of CD4 count of patients will be increased by 0.06317 when the hemoglobin level of patients increased by one (Table 6). This result consistent with a previous finding [17].
Conclusion
This study used a series of repeated measurements over time at the lowest level is nested with the individual patients at the highest level. Such nested structures are typically strong hierarchies because 63% of the variation for CD4 count existed between patients and the remaining 37% of variation existing within patients. Therefore, multilevel modeling considered variability between, and within patients. This study determined the determinants of CD4 cell count among antiretroviral therapy attendants of HIV infected adults follow up in Gonder teaching referral hospital, Gonder, Ethiopia.
From this study, hemoglobin level and weight of patients were statistically significant at a 5% level of significance for the log of CD4 count of patients follow up in Gonder teaching referral hospital, Gonder, Ethiopia. Moreover, the result of the study shows that the log of CD4 count of patients increased when hemoglobin level and weight of patients increased.
Availability of data and materials
The raw data used in this study can be accessed from the Gondar Teaching Referral Hospital.
Abbreviations
 SAS:

Statistical analysis system
 AIDS:

Acquired immunodeficiency syndrome
 HIV:

Human immunodeficiency virus
 WHO:

World health organization
 ART:

Antiretroviral therapy
 GC:

Gregorian calendar
 R^{2} :

Coefficient of determination
 ICC:

Intra class correlation
 SD:

Standard deviation
 AIC:

Akaki information criteria
 BIC:

Bayesian information criteria
 DIC:

Deviance information criteria
 CD4:

Cluster of differentiation four
 HAART:

Highly active antiretroviral therapy
 TB:

Tuberculosis
 UNAIDS:

United nation report on acquired immune deficiency syndrome
 DF:

Degree freedom
References
 1.
Adams M, Luguterah A. Longitudinal analysis of change in CD4+ cell counts of HIV1 patients on antiretroviral therapy (ART) in the Builsa district hospital. Eur Sci J. 2013. https://0doiorg.brum.beds.ac.uk/10.19044/esj.2013.v9n33p%25p.
 2.
Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308(5728):1582–3.
 3.
Alemu AW, Sebastián MS. Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Global Health Action. 2010;3(1):5398.
 4.
Sang R, Miruka F. Factors associated with virologic failure amongst adults on antiretroviral therapy in Nyanza region, Kenya. IOSR J Dent Med Sci. 2016;15(7):10–21.
 5.
Shannon K, Montaner JS. The politics and policies of HIV prevention in sex work. Lancet Infect Dis. 2012;12(7):500–2.
 6.
Bowen L. Applied multilevel analysis: a practical guide. Jos WR Twisk. Oxford University Press; 2007.
 7.
Curran PJ, Obeidat K, Losardo D. Twelve frequently asked questions about growth curve modeling. J Cognit Dev. 2010;11(2):121–36.
 8.
Burchinal MR, Nelson L, Poe M IV. Growth curve analysis: an introduction to various methods for analyzing longitudinal data. Monogr Soc Res Child Dev. 2006;71(3):65–87.
 9.
Steele F. Multilevel models for longitudinal data. J R Stat Soc Ser A. 2008;171(1):5–19.
 10.
Hox JJ, Moerbeek M, Van de Schoot R. Multilevel analysis: techniques and applications. Abingdon: Routledge; 2017.
 11.
Johnson M. Individual growth analysis using PROC MIXED. SAS User Group International; 2002, p. 27.
 12.
Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Stat Med. 2000;19(13):1793–819.
 13.
Singer JD. Fitting individual growth models using SAS PROC MIXED. Modeling intraindividual variability with repeated measures data: methods and applications; 2002, p. 135–70.
 14.
McCulloch CE, Neuhaus JM. Prediction of random effects in linear and generalized linear models under model misspecification. Biometrics. 2011;67(1):270–9.
 15.
Katlama C, Esposito R, Gatell JM, Goffard JC, Grinsztejn B, Pozniak A, Rockstroh J, Stoehr A, Vetter N, Yeni P, Parys W. Efficacy and safety of TMC114/ritonavir in treatmentexperienced HIV patients: 24week results of POWER 1. Aids. 2007;21(4):395–402.
 16.
Alemu H, Haile Mariam D, Tsui A, Ahmed S, Shewamare A. Effect of depressive symptoms and social support on weight and CD4 count increase at HIV clinic in Ethiopia. AIDS Care. 2012;24(7):866–76.
 17.
Lewden C, Raffi F, Cuzin L, Cailleton V, Vildé JL, Chêne G, Allavena C, Salamon R, APROCO Study Group. Factors associated with mortality in human immunodeficiency virus type 1–infected adults initiating protease inhibitor–containing therapy: role of education level and of early transaminase level elevation (APROCO–ANRS EP11 Study). J Infect Dis. 2002;186(5):710–4.
Acknowledgements
Gondar Teaching Referral Hospital Director and all staff are gratefully acknowledged for the data they supplied for this health research. Authors are thankful to his wife and little child for the motivation to write this paper.
Funding
None.
Author information
Affiliations
Contributions
KK have made substantial contribution to conception, design, analysis and interpretation of data and involved in drafting the manuscript, revising it critically for important intellectual content and all have given final approval of the version to be published.
Corresponding author
Ethics declarations
Ethical approval and consent to participate
Letter of ethical clearance was obtained from Bahir Dar University, Department of Statistics and submitted to the University of Gonder Teaching Referral Hospital to get permission to conduct the research. This study was developed in accordance with established legislation and complies with the norms of good clinical practice, and informed consent was being not necessary as personal identifying information was kept separate from the research data. Finally, the study protocol was approved by the ethics committee or medical directors of the University of Gonder Teaching Referral Hospital.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kebede, K. Multilevel model on longitudinal data analysis in determinants of CD4 cell count among antiretroviral therapy attendant of HIV infected adults follow up in Gondar Teaching Referral Hospital, Gonder, Ethiopia. AIDS Res Ther 18, 5 (2021). https://0doiorg.brum.beds.ac.uk/10.1186/s12981020003295
Received:
Accepted:
Published:
DOI: https://0doiorg.brum.beds.ac.uk/10.1186/s12981020003295
Keywords
 CD4 count
 Acquired immunodeficiency syndrome
 Antiretroviral therapy
 Ethiopia
 Multilevel model